MAGELLAN HEALTH INC
Healthcare · Services-Hospitals · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | |
|---|---|---|---|---|---|---|
| Revenue | $1.12B | $1.12B | $4.96B | $5.84B | $4.84B | $4.60B |
| Operating income | — | — | — | — | — | — |
| Net income | $18.3M | $431,000 | $24.2M | $110.2M | $77.9M | $31.4M |
| Total assets | $3.36B | $3.09B | $2.98B | $2.96B | $2.44B | $2.07B |
| Total liabilities | $1.46B | $1.69B | $1.69B | $1.68B | $1.34B | $996.9M |
| Equity | $1.87B | $1.40B | $1.29B | $1.28B | $1.10B | $1.07B |
| EPS (diluted) | $0.74 | $0.02 | $0.97 | $4.51 | $3.22 | $1.21 |
| Shares out. | 24.7M | 23.9M | 24.3M | 23.6M | 24.7M | 26.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2020- Operating margin
- —
- Net margin
- 1.6%
- Return on equity
- 1.0%
- Return on assets
- 0.5%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 43.4%
- Debt / equity
- 0.78×
- Book value / share
- $75.71
- Revenue growth (YoY)
- 0.3%
- Net income growth (YoY)
- 4134.3%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2020- Accruals / assets
- −12.9%clean
- Piotroski F-Score
- 6/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 4 good- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventJan 4, 2022
- Other material eventDec 30, 2021
- Results of operationsNov 5, 2021
- Results of operationsAug 5, 2021
- Results of operationsApr 30, 2021
- Shareholder voteMar 31, 2021
- Other material eventMar 19, 2021
- Results of operationsFeb 26, 2021
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AApr 26, 2023
- SC 13G/AFeb 13, 2023
- SC 13GJan 27, 2023
- SC 13GFeb 14, 2022
- SC 13G/ASCHEDULE 13G/AFeb 10, 2022
- SC 13G/ASEC SCHEDULE 13GFeb 8, 2022
- SC 13G/AFeb 2, 2022
- SC 13G/AJan 27, 2022
- SC 13GJan 25, 2022
- 15-12BJan 14, 2022
- SC 13D/AAMENDMENT NO. 4 TO THE SCHEDULE 13DJan 6, 2022
- 4OWNERSHIP DOCUMENTJan 4, 2022
- 4FORM 4 SUBMISSIONJan 4, 2022
- 4FORM 4 SUBMISSIONJan 4, 2022
- 4FORM 4 SUBMISSIONJan 4, 2022
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.